Effects of Visual Function Impairment on Depression in Patients With Glaucoma
Auswirkungen einer Beeinträchtigung der Sehfunktion auf Depression bei Patient:innen mit Glaukom
Actas Españolas de Psiquiatría · 29.10.2026 · 1-9
DOI: 10.62641/aep.2254 ↗Auf einen Blick
Bei 208 Patient:innen mit Glaukom war eine stärkere Sehbeeinträchtigung mit mehr depressiven Symptomen verbunden. Der Zusammenhang war bei längerer Krankheitsdauer ausgeprägter.
Fragestellung
Zusammenhang zwischen Ausmaß der Sehbeeinträchtigung und depressiven Symptomen bei Glaukom; moderiert die Krankheitsdauer diesen Zusammenhang?
Methode
208 Patient:innen mit Glaukom aus einer Klinik; Erfassung klinischer Daten, BCVA, CMT, NEI-VFQ-25 und SDS; Korrelations-, Regressions- und Subgruppenanalysen.
Ergebnisse
Depressive Symptome (SDS ≥ 53) lagen bei 45,67 % vor. BCVA korrelierte negativ mit SDS (r = −0,23; p < 0,001), CMT positiv (r = 0,27; p < 0,001), NEI-VFQ-25 negativ (r = −0,22; p = 0,002).
Schlussfolgerung der Autor:innen
Der Schweregrad der Sehbeeinträchtigung war signifikant mit depressiven Symptomen assoziiert. BCVA, CMT und NEI-VFQ-25 waren unabhängig mit Depression verbunden, stärker bei längerer Krankheitsdauer.
Kernaussagen
- Depressive Symptome lagen bei 45,67 % der Patient:innen vor.
- BCVA, CMT und NEI-VFQ-25 waren mit SDS-Werten assoziiert.
- Bei Krankheitsdauer ≥5 Jahre waren die Zusammenhänge stärker.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Actas Españolas de Psiquiatría, online erschienen am 29.10.2026. Verfasst von Jing Jiang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Background
This study aimed to investigate the relationship between the degree of visual impairment and depressive symptoms in patients with glaucoma, and examine whether disease duration moderates this relationship.
Methods
We enrolled 208 patients with glaucoma who received standardised treatment at The Affiliated Huaian No.1 People’s Hospital of Nanjing Medical University from February 2022 to February 2025. Clinical data and visual function indicators were collected. Patient-reported visual function was assessed using the 25-item National Eye Institute Visual Function Questionnaire (NEI-VFQ-25), and depressive symptoms were assessed using the SelfRating Depression Scale (SDS). Best-corrected visual acuity (BCVA) and central macular thickness (CMT) served as indicators of visual impairment. Statistical analyses, including descriptive statistics, correlation analysis, linear regression analysis and subgroup analysis with Fisher’s r-to-z transformation, were performed using SPSS 26.0 software.
Results
The mean BCVA was 0.31 ± 0.12, and the mean CMT was 263.22 ± 29.01 µm. Depressive symptoms (SDS score ≥ 53) were present in 45.67% of patients. BCVA was negatively correlated with the SDS total score (r = −0.23, p < 0.001), whereas CMT was positively correlated with the SDS total score (r = 0.27, p < 0.001). The NEI-VFQ-25 total score was also negatively correlated with SDS scores (r = −0.22, p = 0.002). Linear regression showed that for every 0.1 increase in BCVA, SDS scores decreased by 1.53 points (p < 0.001); for every 10 µm increase in CMT, SDS scores increased by 0.74 points (p < 0.001). Subgroup analysis and formal interaction testing revealed that disease duration significantly moderated the associations of visual function with depression: the correlations between BCVA (r = −0.44 vs. −0.07, p < 0.010) and NEI-VFQ-25 (r = −0.49 vs. −0.03, p < 0.001) with SDS scores were significantly stronger in patients with longer disease duration (≥5 years), with significant interaction terms (both p < 0.010).
Conclusions
The degree of visual impairment in patients with glaucoma was significantly associated with depressive symptoms. Objective measures (BCVA and CMT) and NEI-VFQ-25 were independently related to depression risk, and these relationships were more pronounced in patients with longer disease duration. Clinical practice should emphasize visual function protection and psychological treatments to improve patients’ mental health.
Zitieren
APA
Jiang, J., Yang, L., Cui, Y., Shang, M., & Wang, F. (2026). Effects of Visual Function Impairment on Depression in Patients With Glaucoma. Actas Españolas de Psiquiatría, 1-9. https://doi.org/10.62641/aep.2254
Vancouver
Jiang J, Yang L, Cui Y, Shang M, Wang F. Effects of Visual Function Impairment on Depression in Patients With Glaucoma. Actas Españolas de Psiquiatría. 2026:1-9. doi:10.62641/aep.2254
BibTeX
@article{Jiang2026,
author = {Jiang, Jing and Yang, Lin and Cui, Yi and Shang, Mengying and Wang, Fang},
title = {Effects of Visual Function Impairment on Depression in Patients With Glaucoma},
journal = {Actas Españolas de Psiquiatría},
year = {2026},
pages = {1--9},
doi = {10.62641/aep.2254}
}
EUVIMED